Correlation Between Jiangsu GDK and China CYTS

Can any of the company-specific risk be diversified away by investing in both Jiangsu GDK and China CYTS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jiangsu GDK and China CYTS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jiangsu GDK Biotechnology and China CYTS Tours, you can compare the effects of market volatilities on Jiangsu GDK and China CYTS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jiangsu GDK with a short position of China CYTS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jiangsu GDK and China CYTS.

Diversification Opportunities for Jiangsu GDK and China CYTS

0.6

Correlation Coefficient

Jiangsu GDK  China CYTS

Poor diversification

The 3 months correlation between Jiangsu and China is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Jiangsu GDK Biotechnology and China CYTS Tours in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China CYTS Tours and Jiangsu GDK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jiangsu GDK Biotechnology are associated (or correlated) with China CYTS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China CYTS Tours has no effect on the direction of Jiangsu GDK i.e., Jiangsu GDK and China CYTS go up and down completely randomly.

Pair Corralation between Jiangsu GDK and China CYTS

Assuming the 90 days trading horizon Jiangsu GDK Biotechnology is expected to under-perform the China CYTS. In addition to that, Jiangsu GDK is 1.57 times more volatile than China CYTS Tours. It trades about -0.53 of its total potential returns per unit of risk. China CYTS Tours is currently generating about -0.21 per unit of volatility. If you would invest  1,055  in China CYTS Tours on October 7, 2024 and sell it today you would lose (77.00) from holding China CYTS Tours or give up 7.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Jiangsu GDK Biotechnology  vs.  China CYTS Tours

Jiangsu GDK Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Jiangsu GDK Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

China CYTS Tours

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China CYTS Tours has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Jiangsu GDK and China CYTS

The main advantage of trading using opposite Jiangsu GDK and China CYTS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jiangsu GDK position performs unexpectedly, China CYTS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China CYTS will offset losses from the drop in China CYTS's long position.

The idea behind Jiangsu GDK Biotechnology and China CYTS Tours pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.